159 related articles for article (PubMed ID: 36800128)
1. Disparities in NCCN Guideline-Compliant Care for Patients with Early-Stage Pancreatic Adenocarcinoma at Minority-Serving versus Non-Minority-Serving Hospitals.
Lima HA; Alaimo L; Moazzam Z; Endo Y; Woldesenbet S; Katayama E; Munir MM; Shaikh C; Ruff SM; Dillhoff M; Beane J; Cloyd J; Ejaz A; Resende V; Pawlik TM
Ann Surg Oncol; 2023 Jul; 30(7):4363-4372. PubMed ID: 36800128
[TBL] [Abstract][Full Text] [Related]
2. Disparities in NCCN Guideline Compliant Care for Resectable Cholangiocarcinoma at Minority-Serving Versus Non-Minority-Serving Hospitals.
Tsilimigras DI; Dalmacy D; Hyer JM; Diaz A; Abbas A; Pawlik TM
Ann Surg Oncol; 2021 Dec; 28(13):8162-8171. PubMed ID: 34036428
[TBL] [Abstract][Full Text] [Related]
3. Disparities in guideline-compliant care for patients with pancreatic ductal adenocarcinoma at minority-versus non-minority-serving hospitals.
Elshami M; Hoehn RS; Ammori JB; Hardacre JM; Selfridge JE; Bajor D; Mohamed A; Chakrabarti S; Mahipal A; Winter JM; Ocuin LM
HPB (Oxford); 2023 Dec; 25(12):1502-1512. PubMed ID: 37558565
[TBL] [Abstract][Full Text] [Related]
4. Disparities in Surgical Treatment of Resectable Pancreatic Adenocarcinoma at Minority Serving Hospitals.
Olecki EJ; Perez Holguin RA; Mayhew MM; Wong WG; Vining CC; Peng JS; Shen C; Dixon MEB
J Surg Res; 2024 Feb; 294():160-168. PubMed ID: 37897875
[TBL] [Abstract][Full Text] [Related]
5. Association of Care at Minority-Serving vs Non-Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic Cancer in the United States.
Cole AP; Nguyen DD; Meirkhanov A; Golshan M; Melnitchouk N; Lipsitz SR; Kilbridge KL; Kibel AS; Cooper Z; Weissman J; Trinh QD
JAMA Netw Open; 2019 Feb; 2(2):e187633. PubMed ID: 30707230
[TBL] [Abstract][Full Text] [Related]
6. Racial Disparities in Treatment for Rectal Cancer at Minority-Serving Hospitals.
Lu PW; Scully RE; Fields AC; Welten VM; Lipsitz SR; Trinh QD; Haider A; Weissman JS; Freund KM; Melnitchouk N
J Gastrointest Surg; 2021 Jul; 25(7):1847-1856. PubMed ID: 32725520
[TBL] [Abstract][Full Text] [Related]
7. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
8. Disparities in early-stage lung cancer outcomes at minority-serving hospitals compared with nonminority serving hospitals.
Deboever N; Correa AM; Feldman H; Mathur U; Hofstetter WL; Mehran RJ; Rice DC; Roth JA; Sepesi B; Swisher SG; Walsh GL; Vaporciyan AA; Antonoff MB; Rajaram R
J Thorac Cardiovasc Surg; 2024 Jan; 167(1):329-337.e4. PubMed ID: 37116780
[TBL] [Abstract][Full Text] [Related]
9. Association of Minority-Serving Hospital Status with Post-Discharge Care Utilization and Expenditures in Gastrointestinal Cancer.
Lima HA; Woldesenbet S; Moazzam Z; Endo Y; Munir MM; Shaikh C; Rueda BO; Alaimo L; Resende V; Pawlik TM
Ann Surg Oncol; 2023 Nov; 30(12):7217-7225. PubMed ID: 37605082
[TBL] [Abstract][Full Text] [Related]
10. The effect of treatment at minority-serving hospitals on outcomes for bladder cancer.
Fletcher SA; Gild P; Cole AP; Vetterlein MW; Kibel AS; Choueiri TK; Sonpavde GP; Preston MA; Pucheril D; Menon M; Sun M; Lipsitz SR; Trinh QD
Urol Oncol; 2018 May; 36(5):238.e7-238.e17. PubMed ID: 29454591
[TBL] [Abstract][Full Text] [Related]
11. ASO Author Reflections: Disparities in NCCN Guideline-Compliant Care for Patients with Early-Stage Pancreatic Adenocarcinoma at Minority-Serving Versus Non-minority-Serving Hospitals.
Lima HA; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Jul; 30(7):4373-4374. PubMed ID: 36808592
[No Abstract] [Full Text] [Related]
12. Impact of Race/Ethnicity and County-Level Vulnerability on Receipt of Surgery Among Older Medicare Beneficiaries With the Diagnosis of Early Pancreatic Cancer.
Azap RA; Diaz A; Hyer JM; Tsilimigras DI; Mirdad RS; Ejaz A; Pawlik TM
Ann Surg Oncol; 2021 Oct; 28(11):6309-6316. PubMed ID: 33844130
[TBL] [Abstract][Full Text] [Related]
13. Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations.
Nguyen DD; Labban M; Briggs L; Wallis CJD; Cole AP; Lipsitz SR; Iyer HS; Rebbeck TR; Weissman JS; Choueiri TK; Trinh QD
Urol Oncol; 2023 May; 41(5):252.e9-252.e17. PubMed ID: 36759298
[TBL] [Abstract][Full Text] [Related]
14. The Association of Guideline-Concordant Sentinel Lymph Node Biopsy for Melanoma at Minority-Serving Hospitals.
Greene AC; Wong WG; Perez Holguin RA; Patel A; Pameijer CR; Shen C
Ann Surg Oncol; 2023 Jun; 30(6):3634-3645. PubMed ID: 36935433
[TBL] [Abstract][Full Text] [Related]
15. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
[TBL] [Abstract][Full Text] [Related]
16. Effect of Medicaid Expansion on Receipt of Definitive Treatment and Time to Treatment Initiation by Racial and Ethnic Minorities and at Minority-Serving Hospitals: A Patient-Level and Facility-Level Analysis of Breast, Colon, Lung, and Prostate Cancer.
Nguyen DD; Paciotti M; Marchese M; Cole AP; Cone EB; Kibel AS; Ortega G; Lipsitz SR; Weissman JS; Trinh QD
JCO Oncol Pract; 2021 May; 17(5):e654-e665. PubMed ID: 33974827
[TBL] [Abstract][Full Text] [Related]
17. Quality of Care in the Treatment of Localized Intermediate and High Risk Prostate Cancer at Minority Serving Hospitals.
Krimphove MJ; Fletcher SA; Cole AP; Berg S; Sun M; Lipsitz SR; Mahal BA; Nguyen PL; Choueiri TK; Kibel AS; Kluth LA; Weissman JS; Trinh QD
J Urol; 2019 Apr; 201(4):735-741. PubMed ID: 30414956
[TBL] [Abstract][Full Text] [Related]
18. Disparities in Pancreatic Ductal Adenocarcinoma-The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes.
Riner AN; Underwood PW; Yang K; Herremans KM; Cameron ME; Chamala S; Qiu P; George TJ; Permuth JB; Merchant NB; Trevino JG
Cancer Med; 2020 Jun; 9(12):4069-4082. PubMed ID: 32285629
[TBL] [Abstract][Full Text] [Related]
19. Disparities in clinical trial enrollment among patients with gastrointestinal cancer relative to minority-serving and safety-netting hospitals.
Khan MMM; Munir MM; Woldesenbet S; Khalil M; Endo Y; Katayama E; Altaf A; Dillhoff M; Obeng-Gyasi S; Pawlik TM
J Gastrointest Surg; 2024 Mar; ():. PubMed ID: 38555017
[TBL] [Abstract][Full Text] [Related]
20. Patterns of Adjuvant Chemotherapy Use and Association With Survival in Adults 80 Years and Older With Pancreatic Adenocarcinoma.
Mehtsun WT; McCleary NJ; Maduekwe UN; Wolpin BM; Schrag D; Wang J
JAMA Oncol; 2022 Jan; 8(1):88-95. PubMed ID: 34854874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
